These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 19796946

  • 1. PolyQ fibrillation in the cell nucleus: who's bad?
    von Mikecz A.
    Trends Cell Biol; 2009 Dec; 19(12):685-91. PubMed ID: 19796946
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins.
    Saunders HM, Bottomley SP.
    Protein Eng Des Sel; 2009 Aug; 22(8):447-51. PubMed ID: 19589877
    [Abstract] [Full Text] [Related]

  • 5. Expanded polyglutamine stretches lead to aberrant transcriptional regulation in polyglutamine diseases.
    Shimohata T, Onodera O, Tsuji S.
    Hum Cell; 2001 Mar; 14(1):17-25. PubMed ID: 11436350
    [Abstract] [Full Text] [Related]

  • 6. Expanded polyglutamine domain possesses nuclear export activity which modulates subcellular localization and toxicity of polyQ disease protein via exportin-1.
    Chan WM, Tsoi H, Wu CC, Wong CH, Cheng TC, Li HY, Lau KF, Shaw PC, Perrimon N, Chan HY.
    Hum Mol Genet; 2011 May 01; 20(9):1738-50. PubMed ID: 21300695
    [Abstract] [Full Text] [Related]

  • 7. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription.
    Shimohata T, Nakajima T, Yamada M, Uchida C, Onodera O, Naruse S, Kimura T, Koide R, Nozaki K, Sano Y, Ishiguro H, Sakoe K, Ooshima T, Sato A, Ikeuchi T, Oyake M, Sato T, Aoyagi Y, Hozumi I, Nagatsu T, Takiyama Y, Nishizawa M, Goto J, Kanazawa I, Davidson I, Tanese N, Takahashi H, Tsuji S.
    Nat Genet; 2000 Sep 01; 26(1):29-36. PubMed ID: 10973244
    [Abstract] [Full Text] [Related]

  • 8. Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity.
    Raspe M, Gillis J, Krol H, Krom S, Bosch K, van Veen H, Reits E.
    J Cell Sci; 2009 Sep 15; 122(Pt 18):3262-71. PubMed ID: 19690053
    [Abstract] [Full Text] [Related]

  • 9. Neuronal toxicity of expanded polyglutamine depends on intracellular distribution in addition to the expression level.
    Satoh M, Shimada A, Kawamura N, Chiba Y, Yoshikawa K, Ishii S, Furukawa A, Kumagai N, Hosokawa M.
    Neuropathology; 2008 Oct 15; 28(5):485-96. PubMed ID: 18384512
    [Abstract] [Full Text] [Related]

  • 10. PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone.
    Park SH, Kukushkin Y, Gupta R, Chen T, Konagai A, Hipp MS, Hayer-Hartl M, Hartl FU.
    Cell; 2013 Jul 03; 154(1):134-45. PubMed ID: 23791384
    [Abstract] [Full Text] [Related]

  • 11. A toxic monomeric conformer of the polyglutamine protein.
    Nagai Y, Inui T, Popiel HA, Fujikake N, Hasegawa K, Urade Y, Goto Y, Naiki H, Toda T.
    Nat Struct Mol Biol; 2007 Apr 03; 14(4):332-40. PubMed ID: 17369839
    [Abstract] [Full Text] [Related]

  • 12. Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones.
    Kubota H, Kitamura A, Nagata K.
    Methods; 2011 Mar 03; 53(3):267-74. PubMed ID: 21195182
    [Abstract] [Full Text] [Related]

  • 13. Monitoring polyglutamine toxicity in yeast.
    Duennwald ML.
    Methods; 2011 Mar 03; 53(3):232-7. PubMed ID: 21144902
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein.
    Fu L, Gao YS, Sztul E.
    Neurobiol Dis; 2005 Dec 03; 20(3):656-65. PubMed ID: 15964198
    [Abstract] [Full Text] [Related]

  • 15. Quantitative feature extraction reveals the status quo of protein fibrillation in the cell nucleus.
    Arnhold F, von Mikecz A.
    Integr Biol (Camb); 2011 Jul 03; 3(7):761-9. PubMed ID: 21687851
    [Abstract] [Full Text] [Related]

  • 16. ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology.
    Klejbor I, Stachowiak EK, Bharali DJ, Roy I, Spodnik I, Morys J, Bergey EJ, Prasad PN, Stachowiak MK.
    J Neurosci Methods; 2007 Sep 30; 165(2):230-43. PubMed ID: 17655935
    [Abstract] [Full Text] [Related]

  • 17. The nuclear ubiquitin-proteasome system.
    von Mikecz A.
    J Cell Sci; 2006 May 15; 119(Pt 10):1977-84. PubMed ID: 16687735
    [Abstract] [Full Text] [Related]

  • 18. Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila.
    Liévens JC, Rival T, Iché M, Chneiweiss H, Birman S.
    Hum Mol Genet; 2005 Mar 01; 14(5):713-24. PubMed ID: 15677486
    [Abstract] [Full Text] [Related]

  • 19. Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases.
    Qi ML, Tagawa K, Enokido Y, Yoshimura N, Wada Y, Watase K, Ishiura S, Kanazawa I, Botas J, Saitoe M, Wanker EE, Okazawa H.
    Nat Cell Biol; 2007 Apr 01; 9(4):402-14. PubMed ID: 17384639
    [Abstract] [Full Text] [Related]

  • 20. Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicity.
    Popiel HA, Nagai Y, Onodera O, Inui T, Fujikake N, Urade Y, Strittmatter WJ, Burke JR, Ichikawa A, Toda T.
    Biochem Biophys Res Commun; 2004 May 14; 317(4):1200-6. PubMed ID: 15094397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.